Experts Reveal 'Major Shortcomings' With FDA Analysis Of Saf

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Related Keywords

Megan Redshaw , Joseph Fraiman , Johnson , Baromedical Research Institute , Pfizer , Drug Administration , Epoch Times , New Orleans , Biologics Effectiveness , Not Sensitive Enough , Detect Safety , Test Margin , Minimize Risks ,